endpoint Clinical and THREAD have announced their partnership to offer sponsors and sites a solution that aims to simplify decentralized trials (DCT) operations and reduce research study timelines.
Through this partnership, endpoint Clinical and THREAD will provide two-way integration for eConsent, screening, and randomization, supporting automation of underlying workflows across the two platforms. The interfacing of systems has a particular impact on sites, as they do not need to duplicate data entry. In addition, this integrated approach aims to simplify operations such as subject creation, screening, assessments, randomization (including dispensing), and subject treatment visits. Two-way communication between the platforms enables data-driven feedback that can inform strategies for patient recruitment, supply procurement, clinical operations, and data management.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.